Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
US8580263B2 · kind B2 · utility
10Cited by
26References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2007 |
| Grant date | Nov 12, 2013 |
| Priority date | — |
| Expiry date | Jan 23, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-EGFR family member antibodies and bispecific antibodies comprising one or more anti-EGFR family member antibodies are disclosed. These antibodies can be used to advantage to specifically target forms of cancer associated with the overexpression of members of the EGFR protein family.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.